Antiplatelet, Anticoagulant, Thrombolytic Flashcards
ASA is reversible/irreversible platelet inhibitors?
irreversible
Drugs that are P2Y12 receptor inhibitor
Clopidogrel, Prasugrel, Ticagrelol, Ticlopidine
P2Y12 receptor inhibitor which shows irreversible platelet inhibition
Clopidogrel, Prasugrel
Direct acting Reversible platelet inhibitor
Ticagrelor
If patient is allergic to Ibuprofen, can a low dose ASA is used?
ASA is not used if patient allergic to any of NSAIDs
RIng present in Ticagrelor
Cyclopentyl-triazolo-pyrimidines
RIng present in Prasugrel & Clopidogrel
Thienopyridine ring system
ASA shows antiplatelet effect for
7 to 10 days.
Drug having CYP2C19 drug interactions.
Clopidogrel (Prodrug activated by CYP2C19). Clopidogrel is a prodrug that requires conversion to thiol metabolite and this thiol group binds with ADP receptor. INtermediate formed is 2-oxo-clopidogrel. Proton pump inhibitor are inhibitors of CYP2C19 and produce Drug interaction. Less interaction with pantoprazole
Is prasugrel a prodrug?
Yes. Activated by hydrolysis in intestine. and metabolized by 3A4 & 2B6
Why Ticlopidine Not used ?
serious agranulocytosis and neutropenia side effects.
MOA of Clopidogrel, prasugrel, ticagrelor and ticlopidine?
1) blocks ADP induced platelet aggregation.
2) Interact with glycoprotein IIb/IIIa (a fibrinogen receptor) resulting in an inhibition of the fibrinogen to form aggregated plug
The minimum dose required ASA to produce antiplatelet effect ?
60 to 80 mg
Strength of schedule II aspirin
80 mg (chewable) behind the counter
Which is Not prodrug? Ticagrelor Ticlopidine Prasugrel Clopidogrel
Ticagrelor
Antiplatelet effect of Ticagrelol last for ?
2 to 8 hours
the drug of choice in patient usually cannot tolerate ASA or in patient with allergic to ASA.
ADP inhibitor
Ticlopidine
hemorrhagic complications(Agranulocytosis,thrombocytopenia ,neutropenia ), Rash and diarrhea CBC 2 wk for 1st 3 months
antiplatelet agents used in stroke prophylaxis in cerebrovascular ischemia or aft er prosthetic valve replacement
Dipyridamole and cilostazol
antiplatelet agents used for intermittent claudication.
cilostazol
Contraindication of P2Y12 receptor inh.
hematopoietic disorders
Hemorrhagic diathesis/intracranial bleeding
severe liver dysfunction.
Storage conditions of P2Y12 receptor inh.
Store at room temperature. Dispense in light-resistant containers. Blister packs should not be exposed to light.
Does clopidogrel require renal dose adjustment?
Clopidogrel hepatic elimination, renal dose adjustment is not necessary.
Mechanism of action of abciximab, eptifibatide , and tirofiban
parenteral agents that reduce the interaction of platelets via the GPIIb/IIIa receptors to fibrinogen.
monoclonal antibody directed against GPIIb/IIIa
Abciximab is the Fab fragment of a monoclonal antibody directed against GPIIb/IIIa